{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:18:21Z","timestamp":1787026701604,"version":"build-2736575974"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32HL116275-12"],"award-info":[{"award-number":["5T32HL116275-12"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sj\u00f6gren\u2019s disease is an autoimmune condition requiring a systemic evaluation that integrates serologic, histopathologic, and glandular assessments for diagnosis. Current 2016 ACR\/EULAR classification criteria includes anti-Ro serology, labial salivary gland biopsy (LSGB), and measures of oral\/ocular dryness. However, oral\/ocular dryness evaluations are rarely performed by rheumatologists during routine clinical care. Thus, the real-world diagnostic value of contemporaneous oral\/ocular dryness testing remains poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the added value of contemporaneous oral\/ocular dryness testing (Schirmer\u2019s test and unstimulated whole salivary flow) in meeting classification criteria for subjects evaluated with suspected Sj\u00f6gren\u2019s disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>73 subjects referred for suspected Sj\u00f6gren\u2019s disease were evaluated. Correlations between LSGB results and dryness tests, as well as LSGB results and anti-Ro serology, were evaluated. 31 subjects completed testing of oral\/ocular dryness (Schirmer\u2019s test and unstimulated whole salivary flow), anti-Ro serology, and LSGB. Diagnostic pathways were analyzed to assess the contributions of non-invasive tests (serologies and oral\/ocular dryness tests) and invasive testing (LSGB) in meeting the threshold for classification criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A significant association (\n                      <jats:italic>p<\/jats:italic>\n                      -value = 0.0263) was observed between LSGB positivity and positive Schirmer\u2019s testing. No significant association was observed between LSGB positivity and anti-Ro positivity, or between LSGB positivity and low unstimulated whole salivary flow. Among those meeting classification criteria for Sj\u00f6gren\u2019s disease, 81% (30\/37) met classification independently of LSGB results. Of those who completed testing, 22 met classification, among whom 68% (15\/22) fulfilled criteria independently of LSGB results. Of these 15 subjects, 8 (53%) had negative LSGB with a focus score &amp;lt;1. While a positive LSGB was mandatory to confirm classification for seronegative subjects, only 11.8% (2\/17) of anti-Ro-positive subjects required LSGB for classification.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Objective oral\/ocular dryness testing, though rarely performed in routine rheumatologic care, is a valuable complement to serology and biopsy in diagnosing Sj\u00f6gren\u2019s disease. While LSGB is essential for confirming classification in anti-Ro-negative subjects, it adds only modest value to meeting classification criteria in anti-Ro-positive subjects relative to contemporaneous glandular dryness testing. These findings support integrating objective dryness measures into routine diagnostic workflows to reduce reliance on invasive biopsies and improve diagnostic accuracy, especially in seropositive populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1594270","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T05:43:28Z","timestamp":1760507008000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Real-world diagnostic value of integrating oral and ocular dryness testing in suspected Sj\u00f6gren\u2019s disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Eman","family":"Seyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Akaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"O\u2019Dea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thao","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahmatullah W.","family":"Rahmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon M.","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/nejmcp1702514","article-title":"Primary Sj\u00f6gren\u2019s syndrome.","volume":"378","author":"Mariette","year":"2018","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejr.2019.05.003","article-title":"Duration till diagnosis and clinical profile of Sj\u00f6gren\u2019s syndrome: data from real clinical practice in a single-center cohort.","volume":"42","author":"Kuryata","year":"2019","journal-title":"Egyptian Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/healthcare9030363","article-title":"Diagnostic delay in patients with primary Sj\u00f6gren\u2019s syndrome: a population-based cohort study in Taiwan.","volume":"9","author":"Huang","year":"2021","journal-title":"Healthcare."},{"key":"B4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American college of rheumatology\/European league against rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts.","volume":"69","author":"Shiboski","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1002\/acr.23173","article-title":"Prevalence of primary Sj\u00f6gren\u2019s syndrome in a us population-based cohort.","volume":"69","author":"Maciel","year":"2017","journal-title":"Arthritis Care Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12891-015-0482-9","article-title":"Clinical characteristics and biopsy accuracy in suspected cases of Sj\u00f6gren\u2019s syndrome referred to labial salivary gland biopsy.","volume":"16","author":"Giovelli","year":"2015","journal-title":"BMC Musculoskeletal Disord."},{"key":"B7","author":"Brott","year":"2025","journal-title":"Schirmer Test."},{"key":"B8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.14219\/jada.archive.2008.0353","article-title":"Measuring salivary flow.","volume":"139","author":"Nazavesh","year":"2008","journal-title":"J Am Dental Assoc."},{"key":"B9","doi-asserted-by":"publisher","first-page":"102648","DOI":"10.1016\/j.jaut.2021.102648","article-title":"A biomarker for lymphoma development in Sjogren\u2019s syndrome: salivary gland focus score.","volume":"121","author":"Chatzis","year":"2021","journal-title":"J Autoimmun."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1136\/annrheumdis-2016-210448","article-title":"Standardisation of labial salivary gland histopathology in clinical trials in primary Sj\u00f6gren\u2019s syndrome.","volume":"76","author":"Fisher","year":"2016","journal-title":"Ann Rheumatic Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.berh.2015.04.004","article-title":"The use and abuse of diagnostic\/classification criteria.","volume":"28","author":"June","year":"2014","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1136\/ard.2006.052647","article-title":"Progression of salivary gland dysfunction in patients with Sjogren\u2019s syndrome.","volume":"66","author":"Pijpe","year":"2006","journal-title":"Ann Rheumatic Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3899\/jrheum.200907","article-title":"Correlation between subjective and 360 objective severity of oral and ocular dryness in primary sj\u00f6gren syndrome.","volume":"48","author":"Ripsman","year":"2021","journal-title":"J 361 Rheumatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00296-021-04840-4","article-title":"Is it possible to not perform salivary gland biopsy in targeted patients according to unstimulated salivary flow results in patients with suspected Sj\u00f6gren\u2019s syndrome?","volume":"41","author":"Sebastian","year":"2021","journal-title":"Rheumatol Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13075-020-2132-3","article-title":"Unstimulated whole saliva flow for diagnosis of primary Sj\u00f6gren\u2019s syndrome: time to revisit the threshold?","volume":"22","author":"Lacombe","year":"2020","journal-title":"Arthritis Res Therapy."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1002\/art.30295","article-title":"Whole stimulated salivary flow: correlation with the pathology of inflammation and damage in minor salivary gland biopsy specimens from patients with primary Sj\u00f6gren\u2019s syndrome but not patients with sicca.","volume":"63","author":"Arthur, Shen","year":"2011","journal-title":"Arthritis Rheumatism."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.55563\/clinexprheumatol\/gqvyus","article-title":"Clinical and laboratory findings of primary Sj\u00f6gren\u2019s syndrome patients without sicca symptoms.","volume":"40","author":"Chatzis","year":"2022","journal-title":"Clin Exp Rheumatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1594270\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T05:43:29Z","timestamp":1760507009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1594270\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":17,"alternative-id":["10.3389\/fmed.2025.1594270"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1594270","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"article-number":"1594270"}}